Brown Advisory’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-56
Closed -$1K 1251
2022
Q3
$1K Hold
56
﹤0.01% 1134
2022
Q2
$3K Hold
56
﹤0.01% 1102
2022
Q1
$8K Hold
56
﹤0.01% 1108
2021
Q4
$10K Hold
56
﹤0.01% 1235
2021
Q3
$28K Hold
56
﹤0.01% 1101
2021
Q2
$28K Hold
56
﹤0.01% 1065
2021
Q1
$28K Hold
56
﹤0.01% 1074
2020
Q4
$27K Hold
56
﹤0.01% 1012
2020
Q3
$16K Hold
56
﹤0.01% 959
2020
Q2
$11K Hold
56
﹤0.01% 943
2020
Q1
$7K Hold
56
﹤0.01% 935
2019
Q4
$10K Hold
56
﹤0.01% 1033
2019
Q3
$8K Hold
56
﹤0.01% 1004
2019
Q2
$6K Buy
+56
New +$8.87K ﹤0.01% 1023
2018
Q1
Sell
-56
Closed -$68K 1311
2017
Q4
$68K Hold
56
﹤0.01% 1196
2017
Q3
$10K Hold
56
﹤0.01% 1182
2017
Q2
$9K Hold
56
﹤0.01% 1210
2017
Q1
$13K Hold
56
﹤0.01% 1155
2016
Q4
$15K Sell
56
-55
-50% -$13.1K ﹤0.01% 1121
2016
Q3
$25K Buy
111
+55
+98% +$15.4K ﹤0.01% 1063
2016
Q2
$22K Hold
56
﹤0.01% 1040
2016
Q1
$38K Hold
56
﹤0.01% 983
2015
Q4
$58K Hold
56
﹤0.01% 941
2015
Q3
$48K Hold
56
﹤0.01% 923
2015
Q2
$40K Hold
56
﹤0.01% 855
2015
Q1
$126K Hold
56
﹤0.01% 905
2014
Q4
$57K Hold
56
﹤0.01% 914
2014
Q3
$59K Buy
+56
New +$94.3K ﹤0.01% 932

Other funds holding AMPE

Brown Advisory's AMPE Position: Q4 2022 in Review

Brown Advisory sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 56 shares — an estimated $1K sold.

Brown Advisory first reported a position in AMPE in Q3 2014 and held it in 28 quarters. The position peaked at $126K in Q1 2015. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

  • Brown Advisory reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
  • Brown Advisory sold 56 Ampio Pharmaceuticals Inc. shares in Q4 2022, an estimated $1K.
  • Brown Advisory first reported a position in Ampio Pharmaceuticals Inc. in Q3 2014 and held it in 28 quarters.
  • Brown Advisory's Ampio Pharmaceuticals Inc. position peaked at $126K in Q1 2015.
  • 32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on Brown Advisory's 13F filing for Q4 2022, filed 13 Feb 2023.